MALARIA RESEARCH AND TRAINING PROGRAM IN ZIMBABWE

津巴布韦疟疾研究和培训项目

基本信息

  • 批准号:
    6395018
  • 负责人:
  • 金额:
    $ 15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-29 至 2005-02-28
  • 项目状态:
    已结题

项目摘要

The Malaria Research and Training Program in Zimbabwe (MRTPZ) will link the research and educational opportunities of the Molecular Microbiology and Immunology (MMI) Department of the Johns Hopkins School of Public Health with the internationally known Blair Research Institute (BRI) and the Biomedical Research and Training Institute (BRTI) for the purpose of invigorating the existing malaria prevention and control infrastructure of Zimbabwe. The long-term objective will be to fortify and sustain a center of excellence in an African malaria endemic setting. The MRTPZ will knit comprehensive research training of two pre-doctoral and two masters level students at MMI with home country education training in immunologic aspects of malaria transmission control, characterization of drug resistance patterns, vector control strategies, community involvement in malaria control and research methods training. The BRI is the lead government agency charged with management of scientific research and training on Zimbabwe health problems. Malaria control is one of the three priority areas in the national health strategy. The Department of MMI conducts research and trains scientists in the basic mechanisms of infectious diseases and host responses with the underlying School of Public Health philosophy that employs state-of-the-art scientific approaches to public health problems of global significance. The malaria research projects, initiated at MMI but conducted in Zimbabwe will provide a structure for the application of theoretical knowledge gained from comprehensive courses in molecular biology, microbiology, immunology, ecology and-population genetics to the issues related to malaria epidemiology, vector biology, immunology and vaccines, anti malaria drugs, pathogenesis and health systems and operational methods. An essential aspect of the training program, includes a requirement to participate in seminars, research forums, journal clubs, national and international scientific meetings and to participate in the various training courses to be offered in Zimbabwe jointly by the faculty from Hopkins, BRI and BRTI. The training program will be structured to meet the program goals and closely supervised by the MRTPZ advisory committee.
津巴布韦疟疾研究和培训计划(MRTPZ)将把约翰·霍普金斯公共卫生学院分子微生物学和免疫学(MMI)系的研究和教育机会与国际知名的布莱尔研究所(BRI)和生物医学研究和培训研究所(BRTI)联系起来,以振兴津巴布韦现有的疟疾预防和控制基础设施。长期目标将是在非洲疟疾流行地区加强和维持一个英才中心。MRTPZ将在MMI对两名博士前和两名硕士生进行综合研究培训,并在疟疾传播控制的免疫学方面进行母国教育培训,描述耐药性模式,病媒控制战略,社区参与疟疾控制和研究方法培训。BRI是负责津巴布韦健康问题科学研究和培训管理的主要政府机构。控制疟疾是国家卫生战略的三个优先领域之一。MMI的部门进行研究和培训科学家在传染病和宿主反应的基本机制与公共卫生哲学的基础学校,采用国家的最先进的科学方法,以全球意义的公共卫生问题。在MMI发起但在津巴布韦进行的疟疾研究项目将提供一个结构,将从分子生物学、微生物学、免疫学、生态学和人口遗传学综合课程中获得的理论知识应用于与疟疾流行病学、病媒生物学、免疫学和疫苗、抗疟疾药物、发病机理和卫生系统以及操作方法有关的问题。培训计划的一个重要方面,包括要求参加研讨会,研究论坛,期刊俱乐部,国家和国际科学会议,并参加由霍普金斯,BRI和BRTI的教师在津巴布韦联合提供的各种培训课程。培训计划的结构将符合计划目标,并由MRTPZ咨询委员会密切监督。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nirbhay Kumar其他文献

Nirbhay Kumar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nirbhay Kumar', 18)}}的其他基金

Combination Vaccines to Interrupt Malaria Transmission
阻断疟疾传播的联合疫苗
  • 批准号:
    9750618
  • 财政年份:
    2017
  • 资助金额:
    $ 15万
  • 项目类别:
Combination Vaccines to Interrupt Malaria Transmission
阻断疟疾传播的联合疫苗
  • 批准号:
    9381629
  • 财政年份:
    2017
  • 资助金额:
    $ 15万
  • 项目类别:
Identification of Transmission blocking epitopes on P. vivax 48/45 protein
间日疟原虫 48/45 蛋白上传播阻断表位的鉴定
  • 批准号:
    8986156
  • 财政年份:
    2014
  • 资助金额:
    $ 15万
  • 项目类别:
Rational Approach to Optimize Immune Potency of DNA Vaccines
优化 DNA 疫苗免疫效力的合理方法
  • 批准号:
    8676649
  • 财政年份:
    2013
  • 资助金额:
    $ 15万
  • 项目类别:
Rational Approach to Optimize Immune Potency of DNA Vaccines
优化 DNA 疫苗免疫效力的合理方法
  • 批准号:
    8535062
  • 财政年份:
    2013
  • 资助金额:
    $ 15万
  • 项目类别:
Malaria Vaccine Adjuvant Immunogenicity and Safety
疟疾疫苗佐剂的免疫原性和安全性
  • 批准号:
    8351069
  • 财政年份:
    2012
  • 资助金额:
    $ 15万
  • 项目类别:
Malaria Vaccine Adjuvant Immunogenicity and Safety
疟疾疫苗佐剂的免疫原性和安全性
  • 批准号:
    8515930
  • 财政年份:
    2012
  • 资助金额:
    $ 15万
  • 项目类别:
A DNA vaccine to prevent transmission of human malaria
预防人类疟疾传播的 DNA 疫苗
  • 批准号:
    7893555
  • 财政年份:
    2010
  • 资助金额:
    $ 15万
  • 项目类别:
Plasmodium Recombination of Machinery
机械的疟原虫重组
  • 批准号:
    7834524
  • 财政年份:
    2009
  • 资助金额:
    $ 15万
  • 项目类别:
Plasmodium Recombination of Machinery
机械的疟原虫重组
  • 批准号:
    7630336
  • 财政年份:
    2008
  • 资助金额:
    $ 15万
  • 项目类别:

相似海外基金

Meiosis in Plasmodium: How does it work?
疟原虫减数分裂:它是如何运作的?
  • 批准号:
    BB/X014681/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15万
  • 项目类别:
    Research Grant
Meiosis in Plasmodium: How does it work?
疟原虫减数分裂:它是如何运作的?
  • 批准号:
    BB/X014452/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15万
  • 项目类别:
    Research Grant
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
消灭前环境中恶性疟原虫疟疾的基因组学和血清流行病学
  • 批准号:
    10666280
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
Chemical Biology Strategies to Resolve Plasmodium Heat Shock Protein Function
解决疟原虫热休克蛋白功能的化学生物学策略
  • 批准号:
    10734886
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
Exocytosis of Plasmodium egress and invasion organelles
疟原虫出口和入侵细胞器的胞吐作用
  • 批准号:
    10888455
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
Comprehensive characterization of the genetic factors and the host immune response associated to protection from clinical Plasmodium vivax malaria
与预防临床间日疟原虫疟疾相关的遗传因素和宿主免疫反应的综合特征
  • 批准号:
    10634775
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
Developing inhibitors of Plasmodium Acetyl CoA Synthetase as new multistage antimalarials
开发疟原虫乙酰辅酶A合成酶抑制剂作为新型多级抗疟药
  • 批准号:
    MR/X030202/1
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
    Research Grant
Optimising a High Efficacy Plasmodium vivax Malaria Vaccine (OptiViVax)
优化高效间日疟原虫疟疾疫苗 (OptiViVax)
  • 批准号:
    10079676
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
    EU-Funded
Extent, dynamics and mechanisms of Plasmodium vivax immune evasion caused by PvDBP gene amplification
PvDBP基因扩增引起间日疟原虫免疫逃避的程度、动态及机制
  • 批准号:
    10734028
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites
寄生虫和宿主细胞因子参与间日疟原虫休眠子的形成和持续存在
  • 批准号:
    10564073
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了